Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
| Status: | Recruiting |
|---|---|
| Conditions: | Skin Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/16/2018 |
| Start Date: | June 3, 2010 |
| End Date: | January 2020 |
| Contact: | VICC Clinical Trials Information Program, RN |
| Phone: | 800-811-8480 |
The purpose of this research is to identify biological characteristics occurring in the
initiation and progression of melanoma.
initiation and progression of melanoma.
Inclusion criteria
- Pathologically-proven diagnosis of melanoma.
- Patient must have a test or procedure that has the potential to provide left-over
tissue that can be banked for future research purposes OR the patient has already had
a diagnostic or therapeutic procedure but who has not yet been approached to
participate is also eligible.
Exclusion criteria
- Any patient with significant contraindications to venipuncture (e.g., severe anemia)
will be excluded from blood collection procedures. However, if the patient provides
consent and a paraffin-embedded block or 10-15 unstained slides of their tissue
diagnosis, they will not be excluded from this protocol.
- Any patient unable or unwilling to provide consent.
We found this trial at
1
site
Nashville, Tennessee
Principal Investigator: Jeffrey Sosman, MD
Phone: 800-811-8480
Click here to add this to my saved trials
